publication date: Oct. 6, 2017
Issue 37 - Oct. 6, 2017
  • Former American Cancer Society CEO John Seffrin endorses cancer research venture funded by Philip Morris

    Philip Morris International, the tobacco company, is spending $1 billion over 12 years on “cancer research,” which will be funded through something called the Foundation for a Smoke-Free World.

    Here at The Cancer Letter, a news item of this sort might have been easily chalked up to crafty PR tactics and thrown the heck out.

    And it would have been, were it not for this tidbit: the press release included a gushing quote from a gentleman named John Seffrin.

  • How PR firms created “dialogue” structure used by cancer groups and tobacco clients

    In January 2000, The Cancer Letter was working on a story about what seemed to be a strange political structure that was being put together by the American Cancer Society.
    The new organization was called the National Dialogue on Cancer, and its objective was to bring everyone interested in cancer into the same political process, and, in the process, to rewrite the National Cancer Act.

    The “dialogue,” which didn’t look like anything I ever saw in cancer politics, was being run—and presumably was set up—by Shandwick International, a PR firm.

  • Conversation with the Cancer Letter

    Matt Myers: Philip Morris has a long history of funding what it calls independent research by previously credible researchers

    The Foundation for Tobacco-Free World is unlikely to win hearts and minds in the tobacco control community, said Matt Myers, president of the Campaign for Tobacco-Free Kids.

    The new foundation, which received an $80 million-a-year funding commitment from Philip Morris International, has the support of John Seffrin, former CEO of the American Cancer Society.

    If it is to gain credibility, the group would now need to recruit a board of directors who would be willing to stake their reputations on a venture funded by the makers of Marlboro cigarettes.

  • Conversation with the Cancer Letter

    Allan Erickson: “I think Philip Morris has a long-term goal of a smoke-free world

    Through the controversies triggered by the National Dialogue on Cancer, John Seffrin relied on his ACS ally Allan Erickson.

    Erickson now runs a small group called the National Tobacco Reform Initiative, which includes Seffrin and Derek Yach, head of the Foundation for a Smoke-Free World, which received funding from Philip Morris International to spend $80 million a year on cancer research.

  • Guest Editorial

    The Write Treatment; when a writing workshop is a part of cancer treatment

     

    I was diagnosed with breast cancer in 2008 and underwent treatment until 2010 at Beth Israel Hospital, now Mount Sinai, in New York. A year after finishing treatment I was thrilled to find out that my novel, Stalina, was a winner of the Amazon Debut Novel Award Contest.

    The prize was a publishing contract. My cancer diagnosis was life changing, but so was becoming a published author. Soon after receiving the wonderful news about my novel, I found signs of a possible relapse of the cancer. Fortunately, tests came back negative. The angst I experienced was an acknowledgment that cancer would always be part of my psyche, if not my body. I wanted to find a constructive way to face these anxieties. I wanted to find a way to give back to the community of patients, doctors and nurses, friends, colleagues, and family who supported me throughout my cancer journey.

  • In Brief

    • Sunil Sharma joins TGen, City of Hope and HonorHealth
    • Wisconsin state budget expands precision medicine in cancer
  • Drugs & Targets

    • FDA approves sNDA for Alunbrig tablets, Takeda announces  
    • FDA grants priority review for Genentech’s Perjeta in adjuvant HER2+ early breast cancer
    • Mylan launches generic Gleevec tablets
    • Amgen, CytomX Therapeutics form  immuno-oncology collaboration

Copyright (c) 2017 The Cancer Letter Inc.